• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC SILIKON 1000 OIL; FLUID, INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC SILIKON 1000 OIL; FLUID, INTRAOCULAR Back to Search Results
Catalog Number 8065601187
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 04/01/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.Linton e, jasani k.Subretinal silicone oil: oct imaging findings and surgical management of a rare and unusual iatrogenic complication of retinal detachment surgery.Bmj case rep/ 2023.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A literature article reported that a patient with underlying condition of floaters and foggy vision in his right eye, macular off retinal detachment with a super nasal horseshoe tear underwent vitrectomy using an ophthalmic viscosurgical device (ovd) as tamponade.After routine vitrectomy, retinal breaks were identified and marked with diathermy.Subretinal fluid was then drained prior to end laser retinopexy around the retinal breaks.Fluid air exchange was performed and while completing the peripheral end laser, the infusion line was displaced and the eye became hypotonous.Post application of ovd as tamponade and all ports were sutured, the retina appeared flat.Visual acuity on postoperative day 1 was demonstrated 1.0 logmar in the right eye and the intraocular pressure (iop) was 13 mm hg.The suprachoroidal hemorrhage had almost fully resolved aside from a small residual area superiorly.Optos color images (optos, california) and heidelberg optical coherence tomography (oct) images of the right eye on day 1 postoperatively demonstrate the subretinal bubbles (arrows).The oct demonstrates a large convex subretinal elevation with hypo reflective choroidal shadow at the edges of the bubble (arrow).There were also several smaller subretinal bubbles seen around the posterior pole (arrows).Upon follow up demonstrated persistence of the subretinal bubbles and no migration or shrinkage hence it was decided to remove bubbles form retina.A small drainage retinotomy was made over the main bubble, and oil bubbles were visibly released, a further retinotomy was made over the other large inferior retained oil bubble which was successfully drained.Fluid air exchange successfully flattened the retina, and a temporary gas tamponade was used.
 
Additional Manufacturer Narrative
No lot code was reported by the customer; therefore, lot specific evaluation cannot be completed.Root cause for the complaint condition could not be determined.Potential root causes: solution quality issue ¿chemistry and microbiology data must meet regulatory requirements prior to release.Consumer mishandling - no conclusion can be made regarding the contribution of consumer mishandling as this factor is outside the control of the manufacturing facility.Event related to consumer physiology ¿ no conclusion can be made regarding the contribution of unique consumer physiology as this factor is outside the control of the manufacturing facility.Event related to surgical technique ¿ no conclusion can be made regarding the contribution of surgical technique.The product labeling for ophthalmic products provides indications for use, contraindications, warnings, precautions, and directions for use to ensure proper use of the product.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SILIKON 1000 OIL
Common Device Name
FLUID, INTRAOCULAR
Manufacturer (Section D)
ALCON RESEARCH, LLC
6201 south freeway
fort worth TX 76134
Manufacturer (Section G)
ALCON RESEARCH, LLC
6201 south freeway
fort worth TX 76134
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key16830780
Report Number1610287-2023-00017
Device Sequence Number19287904
Product Code LWL
UDI-Device Identifier00380656011873
UDI-Public00380656011873
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
P950008
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number8065601187
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/05/2023
Supplement Date Received by Manufacturer07/06/2023
Initial Report FDA Received Date04/28/2023
Supplement Report FDA Received Date07/29/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CONSTELLATION SYSTEM.; DIATHERMY.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age50 YR
Patient SexMale
-
-